620 results on '"Miyairi, Isao"'
Search Results
202. Human Genetic Factors and Respiratory Syncytial Virus Disease Severity
- Author
-
Miyairi, Isao, primary and DeVincenzo, John P., additional
- Published
- 2008
- Full Text
- View/download PDF
203. The p47 GTPases Iigp2 and Irgb10 Regulate Innate Immunity and Inflammation to Murine Chlamydia psittaci Infection
- Author
-
Miyairi, Isao, primary, Tatireddigari, Venkat R. R. Arva, additional, Mahdi, Olaimatu S., additional, Rose, Lorne A., additional, Belland, Robert J., additional, Lu, Lu, additional, Williams, Robert W., additional, and Byrne, Gerald I., additional
- Published
- 2007
- Full Text
- View/download PDF
204. Reply to Schachter and Dawson
- Author
-
Miyairi, Isao, primary, Mahdi, Olaimatu S., additional, Ouellette, Scot P., additional, Belland, Robert J., additional, and Byrne, Gerald I., additional
- Published
- 2007
- Full Text
- View/download PDF
205. Different Growth Rates ofChlamydia trachomatisBiovars Reflect Pathotype
- Author
-
Miyairi, Isao, primary, Mahdi, Olaimatu S., additional, Ouellette, Scot P., additional, Belland, Robert J., additional, and Byrne, Gerald I., additional
- Published
- 2006
- Full Text
- View/download PDF
206. Group B Streptococcal Ventriculitis: A Report of Three Cases and Literature Review
- Author
-
Miyairi, Isao, primary, Causey, Karima T., additional, DeVincenzo, John P., additional, and Buckingham, Steven C., additional
- Published
- 2006
- Full Text
- View/download PDF
207. Chlamydia and programmed cell death
- Author
-
Miyairi, Isao, primary and Byrne, Gerald I, additional
- Published
- 2006
- Full Text
- View/download PDF
208. Acute Necrotizing Ulcerative Gingivitis and Bacteremia Caused by Stenotrophomonas maltophilia in an Immunocompromised Host
- Author
-
Miyairi, Isao, primary, Franklin, Jeremy A., additional, Andreansky, Martin, additional, Knapp, Katherine M., additional, and Hayden, Randall T., additional
- Published
- 2005
- Full Text
- View/download PDF
209. Neonatal invasive group A streptococcal disease: case report and review of the literature
- Author
-
MIYAIRI, ISAO, primary, BERLINGIERI, DOMINIC, additional, PROTIC, JOHN, additional, and BELKO, JOHN, additional
- Published
- 2004
- Full Text
- View/download PDF
210. Risk Factors for Bloodstream Infection After Living-donor Liver Transplantation in Children
- Author
-
Shoji, Kensuke, Funaki, Takanori, Kasahara, Mureo, Sakamoto, Seisuke, Fukuda, Akinari, Vaida, Florin, Ito, Kenta, Miyairi, Isao, and Saitoh, Akihiko
- Abstract
Supplemental Digital Content is available in the text.
- Published
- 2015
- Full Text
- View/download PDF
211. A Case of Recrudescent Tuberculos Lymphadenitis 3 Years Following BCG Vaccination.
- Author
-
Shinozuka, Toru, primary, Tachi, Kazuhiro, additional, Miyairi, Isao, additional, and Nakajima, Kyoko, additional
- Published
- 1997
- Full Text
- View/download PDF
212. Different Growth Rates of Chlamydia trachomatis Biovars Reflect Pathotype.
- Author
-
Miyairi, Isao, Mahdi, Olaimatu S., Ouellette, Scot P., Belland, Robert J., and Byrne, Gerald I.
- Subjects
- *
CHLAMYDIA trachomatis , *GENETICS , *HELA cells , *CELL culture , *CANCER cells , *CULTURES (Biology) , *CYTOLOGICAL techniques - Abstract
Background. Despite small genomic differences, Chlamydia trachomatis biovars exhibit diverse disease manifestations and different growth rates in vivo and in cell culture models. Methods. Chlamydial inclusion-forming units were enumerated over time in HeLa cells, to evaluate the length of the developmental cycle for C. trachomatis strains A, B, C, and E/Bour (ocular strains) as well as D, E/UW5/Cx, F, and L2 (genital strains). Prototype strains A, D, and L2 were selected for detailed analysis of reticulate body growth, division, and genomic replication. The impact that changing host cells and that coinfection with different strains has on growth was also assessed. Results. The genital strains completed the developmental cycle in 36–44 h, whereas the ocular strains lagged behind considerably. Differences were the result of a longer lag phase (entry plus differentiation) and generation time for the ocular strains. A prototype ocular strain grew faster in conjunctival cells than in cervical cells. Coinfection with genital (D or L2) and ocular strains expedited recovery of the ocular strain. Conclusions. Precise temporal evaluation of the chlamydial developmental cycle for selected genital and ocular C. trachomatis biovars provides a means for investigating genomic differences that define chlamydial pathotype. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
213. Pulmonary Calcification in a Congenital Cytomegalovirus Infection
- Author
-
Uda, Kazuhiro, Sasaki, Yuka, Shoji, Kensuke, and Miyairi, Isao
- Published
- 2017
- Full Text
- View/download PDF
214. Successful Detection and Genotyping of Rubella Virus From Preserved Umbilical Cord of Patients With Congenital Rubella Syndrome.
- Author
-
Miyata, Ippei, Kubo, Takahiko, Miyairi, Isao, Saitoh, Akihiko, and Morimoto, Noriko
- Published
- 2015
- Full Text
- View/download PDF
215. Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5–11 years with underlying diseases: A prospective observational study.
- Author
-
Funaki, Takanori, Yamada, Masaki, Miyake, Kozue, Ueno, Saki, Myojin, Shota, Aiba, Hiroyuki, Matsui, Toshihiro, Ogimi, Chikara, Kato, Hitoshi, Miyairi, Isao, and Shoji, Kensuke
- Subjects
- *
SARS-CoV-2 , *COVID-19 vaccines , *VACCINATION of children , *CORONAVIRUS diseases , *HIV seroconversion , *ANTIBODY formation , *ANTIBODY titer - Abstract
Data on the safety and antibody response of the BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine in children aged 5–11 years with underlying diseases are limited. Thus, our study aimed to address this gap. This prospective observational study investigated the antibody titers for SARS-CoV-2 spike protein receptor-binding domain (S-IgG) and nucleocapsid protein (N-IgG) in patients aged 5–11 years with chronic underlying diseases following two doses of BNT162b2. Additionally, a questionnaire was used to assess adverse events (AEs) arising within 7 days after each dose. Data on severe AEs arising within 28 days after each dose were extracted from the patients' electronic medical records. Among 122 patients, 24.6% (30/122) were immunocompromised. Furthermore, 79 patients experienced at least one AE following vaccination, but all recovered without sequelae, including one severe case after the first dose. The seropositivity rate after the second dose was 99.1% (116/117). Excluding 19 N-IgG-positive patients, the geometric mean antibody titer (GMT) was significantly higher in immunocompetent patients than in immunocompromised patients (1496 U/mL [95% confidence interval 1199–1862] vs. 472 U/mL [200−1119], p = 0.035). Additionally, the GMT of S-IgG was higher in N-IgG-positive patients than in N-IgG-negative patients (8203 [5847–11482] U/mL vs. 1127 [855–1486] U/mL, p < 0.001). BNT162b2 is acceptably safe and immunogenic for children aged 5–11 years with underlying diseases. Although seroconversion was satisfactory in immunocompromised patients, the titers were lower than in immunocompetent patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
216. Trend in antibiotic prescription at pediatric primary emergency medical centers in Japan: A multi-center, cross-sectional study.
- Author
-
Otake, Shogo, Shoji, Takayo, Yamada, Kenta, Kimura, Makoto, Myojin, Shota, Kamiyoshi, Naohiro, Ochi, Fumihiro, Nezu, Mari, Ishida, Akihito, Miyairi, Isao, and Kasai, Masashi
- Subjects
- *
MEDICAL emergencies , *PEDIATRIC emergencies , *MEDICAL centers , *RESPIRATORY infections , *THIRD generation cephalosporins - Abstract
Antimicrobial resistance is a global issue, and implementation of antimicrobial stewardship programs in outpatient settings is crucial. Japan has also focused on outpatient oral antimicrobial stewardship programs and difficulties in standardizing prescriptions have led to overprescription in primary emergency medical centers. There is a lack of research investigating the antibiotic prescription status of pediatric primary emergency medical centers and the benchmark prescription rates in pediatric outpatient settings. We conducted a multi-center, cross-sectional study of seven pediatric primary emergency medical centers located in five prefectures of Japan. We retrospectively extracted data from health claims or directly obtained them from charts at each institution and evaluated trends in the antibiotic prescription rate based on the AWaRe classification between April 2016 and December 2019. Our study included 383,525 encounters, with the most common infectious disease diagnosis being acute upper respiratory tract infection in 93,449 cases (24.4 %). The antibiotic prescription rate during the study period was 7.4 %, representing a decrease of 46 %, from 10.2 % in 2016 to 5.5 % in 2019. The percentage of prescriptions in the Access group increased at all institutions; however, it exceeded 60 % in only three facilities in 2019. The percentage of third-generation cephalosporins varied among facilities, ranging from 1.7 % to 59.4 %, as of 2019. For pediatric primary emergency medical centers where antimicrobial stewardship programs are implemented, we suggest 5 % as a reasonable benchmark level for the antibiotic prescription rate. Prescribing the antibiotics in the Access groups less frequently remains a domestic challenge in Japan. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
217. Nationwide epidemiology and health resource use among children with COVID-19 in Japan.
- Author
-
Okubo, Yusuke, Nakabayashi, Yosuke, Ito, Kenta, Uda, Kazuhiro, and Miyairi, Isao
- Subjects
- *
NUCLEIC acid amplification techniques , *COVID-19 , *COVID-19 pandemic , *ANTIGEN analysis , *DATABASES - Abstract
The COVID-19 pandemic posed substantial challenges to healthcare systems. Understanding the responses of pediatric health services is crucial for future pandemic planning and preparedness, yet such data remains limited. In this retrospective cohort study, we analyzed data from administrative databases developed by Japan Medical Data Center and DeSC Healthcare Inc. The dataset comprised records of 2,612,511 children, totaling 60,224,888 person-months, from January 2020 to May 2022. Multivariate generalized estimation equations were used to examine the incidence rates of COVID-19 and associated health resource use. Our analysis revealed that the incidence rates of COVID-19 gradually increased from Wave I (2.2 cases per 100,000 person-months) to Wave V (177.8cases per 100,000 person-months), with a notable elevation during Wave VI (2367.7 cases per 100,000 person-months). While nucleic acid amplification tests were primarily used during Waves I–V, the use of rapid antigen tests markedly increased in Wave VI. The hospitalization rates increased gradually from 0.2 in Wave I to 10.2 events per 100,000 person-months in Wave VI, and the case-hospitalization risk decreased from 14.9% in Wave II to 0.7% in Wave VI. Additionally, we observed decreasing trends in the use of antibiotics (Wave I, 31.8%; Wave VI, 9.0%), whereas antipyretic use rose from Wave I (56.1%) to Wave VI (86.6%). Our study highlighted essential changes in the nationwide pediatric healthcare system's response to the COVID-19 pandemic. These findings provide valuable insights into the future pandemic planning and preparedness. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
218. Quantitative PCR Assays of Cytomegalovirus and Epstein-Barr Virus in Hemophagocytic Lymphohistiocytosis.
- Author
-
Okazaki, Kana, Imadome, Ken-Ichi, Nakao, Hiro, Miyairi, Isao, and Ishiguro, Akira
- Published
- 2018
- Full Text
- View/download PDF
219. Melting temperature mapping method in children: Rapid identification of pathogenic microbes.
- Author
-
Ishikawa, Takashi, Uejima, Yoji, Okai, Masashi, Shiga, Kyoko, Shoji, Kensuke, Miyairi, Isao, Kato, Motohiro, Morooka, Shintaro, Kubota, Mitsuru, Tagaya, Takashi, Tsuji, Satoshi, Aoki, Satoshi, Ide, Kentaro, Niimi, Hideki, Uchiyama, Toru, Onodera, Masafumi, and Kawai, Toshinao
- Subjects
- *
BACTERIAL DNA , *RIBOSOMAL RNA , *CHILDREN'S hospitals , *PATHOGENIC bacteria , *MELTING , *PHYTOPATHOGENIC bacteria - Abstract
The melting temperature (T m) mapping method (TM) identifies bacterial species by intrinsic patterns of T m values in the 16S ribosomal RNA gene (16S rDNA) extracted directly from whole blood. We examined potential clinical application of TM in children with bloodstream infection (BSI). This was a prospective observational study at a children's hospital in Japan from 2018 to 2021. In patients with diagnosed or suspected BSI, we investigated the match rates of pathogenic bacteria identified by TM and blood culture (BC), the inspection time to identification of TM, and the amount of bacterial DNA in blood samples. The median age of 81 patients (93 samples) was 3.6 years. Of 23 samples identified by TM, 11 samples matched the bacterial species with BC (positive-match rate, 48 %). Of 64 TM-negative samples, 62 samples were negative for BC (negative-match rate, 97 %). Six samples, including one containing two pathogenic bacterial species, were not suitable for TM identification. In total, the matched samples were 73 of 93 samples (match rate, 78 %). There were seven samples identified by TM in BC-negative samples from blood collected after antibiotic therapy. Interestingly, the bacteria were matched with BC before antibiotic administration. These TM samples contained as many 16S rDNA copies as the BC-positive samples. The median inspection time to identification using TM was 4.7 h. In children with BSI, TM had high negative-match rates with BC, the potential to identify the pathogenic bacteria even in patients on antibiotic therapy, and more rapid identification compared to BC. UMIN000041359 https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000047220. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
220. Infection prevention measures and its determinants in childcare facilities during the COVID-19 pandemic: A nationwide survey (2022–2023).
- Author
-
Okubo, Yusuke, Uda, Kazuhiro, Kaki, Mimori, Miyoshi, Shinobu, and Miyairi, Isao
- Subjects
- *
COVID-19 pandemic , *INFECTION prevention , *CHILD care , *CHILDREN'S health , *PANDEMICS - Abstract
The coronavirus disease-2019 (COVID-19) pandemic presented an unprecedented challenge to societies, necessitating adaptations in infection prevention measures. While there is ample data on infection prevention practices in workplace and healthcare settings, comprehensive data specific to childcare facilities has been lacking. We conducted a nationwide web-based survey capturing responses from various childcare facilities (N = 549). This aimed to understand the adaptation in infection prevention measures between fiscal years 2022 and 2023, the status of events and activities, and the factors influencing decision-making related to infection prevention. From 2022 to 2023, most childcare facilities reduced infection prevention practices like mandatory mask-wearing (46.9 %–7.5 %) and eating without conversing (56.5 %–7.4 %), whereas they continued high levels of hand sanitization and checking child's health condition before attendance. The frequency of events and activities (e.g., athletic meets, field trips) increased, with many being held without restrictions. Surprisingly, 62.8 % of facilities used items not recommended for infection prevention. The influence of local government guidelines (risk ratio, 0.69; 95%CI, 0.53–0.90) and the input from junior teachers (risk ratio, 0.85; 95%CI, 0.72–0.99) were associated with reduced risk of using inappropriate items. Furthermore, childcare facilities emphasized the need to collaborate with public health and medical professionals for more accurate and efficient decision-making during pandemics. The survey provides insights into the evolving practices of Japanese childcare facilities during the COVID-19 pandemic. It underscores the importance of refining information sources, enhancing decision-making processes, and fostering collaboration with the medical community for future pandemics and natural disasters. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
221. Development and validation of a new asthma questionnaire to help achieve a high level of control in school-age children and adolescents.
- Author
-
Matsunaga, Mayumi, Sato, Yasunori, Nagao, Mizuho, Ikeda, Masanori, Motomura, Chikako, Kameda, Makoto, Yoshida, Yukinori, Terada, Akihiko, Miyairi, Isao, and Fujisawa, Takao
- Subjects
- *
ASTHMATICS , *ASTHMA , *TEENAGERS , *LOGISTIC regression analysis , *SCHOOL children , *QUESTIONNAIRES - Abstract
Maintaining good asthma control minimizes the risk of exacerbations and lung function decline and is a primary goal of asthma management. The Japanese Pediatric Asthma Guidelines (JPGL) employs different classification criteria for control status from other guidelines, stressing a higher level of control. Based on JPGL, we previously developed a caregiver-completed questionnaire for assessing and achieving best asthma control in preschoolers. In this study, we aimed to develop a questionnaire for school-age children and adolescents. A working questionnaire comprising 14 items for patients and 34 items for caregivers was administered to 362 asthma patients aged 6–15 years and their caregivers. Separately, physicians filled out a questionnaire to determine JPGL-defined control. Logistic regression analysis was performed to construct a model to predict control levels using data from a randomly selected set of completed questionnaires from two-thirds of the subjects. Validation was performed using the remaining questionnaires. A set of 7 questions, encompassing self-assessed control status at the time of the visit and in the past month, and nocturnal/early morning asthma symptoms for patients and frequency of asthma symptoms, dyspnea, rescue beta-agonist use, and asthma hospitalization for caregivers, were selected and the 7-item model showed a good statistical fit with AIC of 110.5. The model has been named the Best Asthma Control Test for School Children and Adolescents (Best ACT-S). Best ACT-S scores differed significantly in the hypothetical direction among the groups of different JPGL-defined control levels, step-up/down treatment decisions, and presence/non-presence of exacerbations in the previous year. The Best ACT-S is a valid questionnaire for children/adolescents aiming for best asthma control. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
222. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients
- Author
-
Saito, Jumpei, Shoji, Kensuke, Oho, Yusuke, Kato, Hiroki, Matsumoto, Shotaro, Aoki, Satoshi, Nakamura, Hidefumi, Ogawa, Takanori, Hasegawa, Mayumi, Yamatani, Akimasa, and Miyairi, Isao
- Abstract
This study investigates the optimal meropenem (MEM) dosing regimen for critically ill pediatric patients, for which there is a lack of pharmacokinetic (PK) studies. We conducted a retrospective single-center PK and pharmacodynamic (PD) analysis of 34 pediatric intensive care unit patients who received MEM.
- Published
- 2020
- Full Text
- View/download PDF
223. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
- Author
-
Tetsuka, Nobuyuki, Yaguchi, Takashi, Machida, Hiroyuki, Ito, Shuichi, and Miyairi, Isao
- Subjects
IMMUNOSUPPRESSIVE agents ,ANTIBIOTICS ,PULMONARY aspergillosis ,VORICONAZOLE ,ASPERGILLUS ,BRONCHOALVEOLAR lavage ,CHEST X rays ,COMPUTED tomography ,COUGH ,DRUG resistance in microorganisms ,NEPHROTIC syndrome ,SPUTUM ,PREDNISOLONE ,IMMUNOCOMPROMISED patients ,LEUKOCYTE count ,DIAGNOSIS ,THERAPEUTICS - Abstract
The article discusses a case of a 12-year-old boy with refractory nephrotic syndrome and invasive pulmonary aspergillosis (IPA) due to azole-resistant Aspergillus lentulus. Topics covered include how the case highlights the importance of obtaining specimens for identification of the causative agent, how Aspergillus lentulus cannot be morphologically differentiated from A. fumigatus, and the importance of identification and susceptibility testing in invasive aspergillosis.
- Published
- 2017
- Full Text
- View/download PDF
224. Acute Necrotizing Ulcerative Gingivitis and Bacteremia Caused by Stenotrophomonas maltophiliain an Immunocompromised Host
- Author
-
Miyairi, Isao, Franklin, Jeremy A., Andreansky, Martin, Knapp, Katherine M., and Hayden, Randall T.
- Abstract
An 8-year-old girl with leukemia developed acute necrotizing ulcerative gingivitis with Stenotrophomonas maltophiliaand herpes simplex virus. Progression to bacteremia with pathologic evidence of osteomyelitis occurred despite appropriate antimicrobial therapy. This case highlights the importance of prompt recognition, debridement and appropriate therapy in immunocompromised patients with acute necrotizing ulcerative gingivitis.
- Published
- 2005
- Full Text
- View/download PDF
225. Recent Prescription Patterns for Children With Acute Infectious Diarrhea.
- Author
-
Okubo, Yusuke, Miyairi, Isao, Michihata, Nobuaki, Morisaki, Naho, Kinoshita, Noriko, Urayama, Kevin Y, and Yasunaga, Hideo
- Published
- 2018
- Full Text
- View/download PDF
226. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents.
- Author
-
Kamei, Koichi, Miyairi, Isao, Ishikura, Kenji, Ogura, Masao, Shoji, Kensuke, Funaki, Takanori, Ito, Reiko, Arai, Katsuhiro, Abe, Jun, Kawai, Toshinao, Onodera, Masafumi, and Ito, Shuichi
- Abstract
Objective: To conduct a prospective study to evaluate the immunogenicity and safety of live attenuated vaccines in patients with nephrotic syndrome receiving immunosuppressive agents.Study Design: Patients with nephrotic syndrome receiving immunosuppressive agents with negative or borderline antibody titers (virus-specific IgG levels <4.0) against measles, rubella, varicella, and/or mumps fulfilling the criteria of cellular and humoral immunity were enrolled. Virus-specific IgG levels were measured using an enzyme immunoassay. The primary endpoint was the seroconversion rate (ie, achievement of virus-specific IgG levels ≥4.0) at 2 months after vaccination. Virus-specific IgG levels at 1 year, breakthrough infections (wild-type infections), and adverse events were also evaluated.Results: A total of 116 vaccinations were administered to 60 patients. Seroconversion rates were 95.7% for measles, 100% for rubella, 61.9% for varicella, and 40.0% for mumps. More patients with a borderline antibody titer before vaccination achieved seroconversion than those with negative antibody titer, with statistical significance after varicella and mumps vaccination. The rate of patients who maintained seropositivity at 1 year after vaccination was 83.3% for measles, 94.1% for rubella, 76.7% for varicella, and 20.0% for mumps. No patient experienced breakthrough infection. No serious adverse events, including vaccine-associated infection, were observed.Conclusion: Immunization with live attenuated vaccines may be immunogenic and is apparently safe in our cohort of patients with nephrotic syndrome receiving immunosuppressive agents if their cellular and humoral immunologic measures are within clinically acceptable levels.Trial Registration: UMIN-CTR UMIN 000007710. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
227. Recent epidemiology of Pneumocystis pneumonia in Japan.
- Author
-
Shoji, Kensuke, Michihata, Nobuaki, Miyairi, Isao, Matsui, Hiroki, Fushimi, Kiyohide, and Yasunaga, Hideo
- Subjects
- *
PNEUMOCYSTIS pneumonia , *INTERLEUKIN receptors , *EPIDEMIOLOGY , *COLLAGEN diseases , *RHEUMATISM - Abstract
The objective of this study was to describe the recent epidemiology of Pneumocystis pneumonia (PCP) in Japan using a nationwide database. We extracted data of inpatients with PCP from the Diagnostic Procedure Combination database, a national inpatient database in Japan, from January 2010 to December 2016. During the study period, 4293 PCP patients were identified, including 4073 adults and 220 children. In adults, the most common comorbidity was hematologic malignancy (31%), followed by diabetes mellitus (30%), rheumatic/collagen diseases (26%), and solid organ tumors (18%). In children, there were few patients with rheumatic diseases (5%) or diabetes mellitus (2%), but immunodeficiency (without human immunodeficiency virus) was more common (28%). Few biological products were used for adult and pediatric patients; CD20 inhibitors, TNF-α inhibitors, interleukin receptor inhibitors, and CTLA-4 inhibitor were used for 8.6% and 2.4%, 1.3% and 0%, 1.2% and 4.7%, and 0.2% and 0% of adult and pediatric patients, respectively. Based on data stratified by bed count, the annual numbers of PCP patients in Japan were estimated as 2221 adults and 123 pediatric patients. The mortality was higher in adults (27%) than in pediatric patients (21%) (P = 0.041). The underlying disease and mortality were apparently different between adult and pediatric PCP patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
228. Association between use of antipyretics and antibody titers after two doses of the BNT162b2 SARS-CoV-2 vaccine in adolescents and young adults with underlying diseases.
- Author
-
Aiba, Hiroyuki, Funaki, Takanori, Yamada, Masaki, Miyake, Kozue, Ueno, Saki, Tao, Chiaki, Myojin, Shota, Matsui, Toshihiro, Ogimi, Chikara, Kato, Hitoshi, Miyairi, Isao, and Shoji, Kensuke
- Subjects
- *
COVID-19 vaccines , *ANTIBODY titer , *YOUNG adults , *ANTIPYRETICS , *TEENAGERS - Abstract
There are few reports on the association between antipyretic use and antibody titers in adolescents and young adults following SARS-CoV-2 vaccination. Multivariable linear regression analyses were performed to examine the association between antipyretic use and antibody titers. The use of antipyretics was not associated with antibody titers (β coefficient [95% CI] = −0.107 [–0.438 to 0.224]). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
229. Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis.
- Author
-
Shoji, Kensuke, Asai, Yusuke, Akiyama, Takayuki, Tsuzuki, Shinya, Matsunaga, Nobuaki, Suzuki, Setsuko, Iwamoto, Noriko, Funaki, Takanori, Miyairi, Isao, and Ohmagari, Norio
- Subjects
- *
SARS-CoV-2 , *REMDESIVIR - Abstract
Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not statistically different (86.7% vs 73.3%, P = 0.333). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
230. Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan.
- Author
-
Uda, Kazuhiro, Okubo, Yusuke, Tsuge, Mitsuru, Tsukahara, Hirokazu, and Miyairi, Isao
- Subjects
- *
CHICKENPOX , *HERPES zoster , *CHICKENPOX vaccines , *COVID-19 pandemic , *COVID-19 vaccines , *COMMUNICABLE diseases , *INFECTION prevention - Abstract
• We evaluated trends of pediatric varicella and herpes zoster incidence for 18 years. • Varicella was largely reduced after the vaccine introduction and COVID-19 pandemic. • The vaccine and COVID-19 pandemic had a small impact on herpes zoster incidence. • Risk of herpes zoster was low in children born after the routine vaccine. To determine the epidemiological trends in pediatric varicella and herpes zoster incidence and changes in healthcare resource use from 2005 to 2022 using a nationally representative database in Japan. We conducted a retrospective observational study consisting of 3.5 million children with 177 million person-months during 2005–2022 using Japan Medical Data Center (JMDC) claims database in Japan. We investigated trends in incidence rates of varicella and herpes zoster and changes in healthcare resource use (e.g., antiviral use, office visits, and healthcare costs) over 18 years. Interrupted time-series analyses were used to investigate the impact of the routine varicella vaccination program in 2014 and infection prevention measures against COVID-19 on incidence rates of varicella and herpes zoster and related healthcare utilization. After the introduction of the routine immunization program in 2014, we observed level changes in incidence rates (45.6 % reduction [95 %CI, 32.9–56.0] of varicella cases, antiviral use (40.9 % reduction [95 %CI, 25.1–53.3]), and relevant healthcare costs (48.7 % reduction [95 %CI, 38.2–57.3]). Furthermore, infection prevention measures against COVID-19 were associated with additional level changes in varicella rates (57.2 % reduction [95 %CI, 44.5–67.1]), antiviral use (65.7 % reduction [59.7–70.8]), and healthcare costs (49.1 % [95 %CI, 32.7–61.6]). In contrast, the changes in incidence and healthcare costs for herpes zoster were relatively small, which showed 9.4 % elevated level change with a decreasing trend and 8.7 % reduced level change with a decreasing trend after the vaccine program and the COVID-19 pandemic. The cumulative incidence of herpes zoster in children born after 2014 was lower than that before 2014. Varicella incidence and healthcare resource use were largely affected by the routine immunization program and infection prevention measures against COVID-19, while these impacts on herpes zoster were relatively small. Our study indicates that immunization and infection prevention measures largely changed pediatric infectious disease practices. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
231. Prognostic factors among patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: A retrospective cohort study using a nationwide inpatient database in Japan.
- Author
-
Myojin, Shota, Michihata, Nobuaki, Shoji, Kensuke, Takanashi, Jun-ichi, Matsui, Hiroki, Fushimi, Kiyohide, Miyairi, Isao, and Yasunaga, Hideo
- Subjects
- *
HEMOLYTIC-uremic syndrome , *PROGNOSIS , *DATABASES , *ESCHERICHIA coli , *COHORT analysis - Abstract
Shiga toxin-producing Escherichia coli (STEC) causes hemorrhagic colitis and hemolytic uremic syndrome (STEC-HUS). Understanding its prognostic factors is essential for immediate interventions. We examined early-phase unfavorable prognostic factors among patients with STEC-HUS using a nationwide database. This is a retrospective cohort study to analyze practice patterns and identify prognostic factors among patients with STEC-HUS. We used the Diagnosis Procedure Combination Database, which includes approximately half of the acute-care hospitalized patients in Japan. We enrolled patients who were hospitalized for STEC-HUS from July 2010 to March 2020. The composite unfavorable outcome included in-hospital death, mechanical ventilation, dialysis, and rehabilitation at discharge. Unfavorable prognostic factors were assessed using a multivariable logistic regression model. We included 615 patients with STEC-HUS (median age, 7 years). Of them, 30 (4.9%) patients had acute encephalopathy and 24 (3.9%) died within 3 months of admission. Unfavorable composite outcome was observed in 124 (20.2%) patients. Significant unfavorable prognostic factors were age of 18 years or older, methylprednisolone pulse therapy, antiepileptic drug administration, and respiratory support within 2 days of admission. Patients requiring early steroid pulse therapy, antiepileptic drugs, and respiratory support were considered to be in poor general condition; such patients should receive aggressive intervention to avoid worse outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
232. The Utility of Performing Anaerobic Blood Cultures in Pediatric Intensive Care Units.
- Author
-
Kato, Hiroki, Shoji, Kensuke, Jinguji, Miyuki, Nishimura, Nao, Nakagawa, Satoshi, and Miyairi, Isao
- Subjects
- *
BACTEREMIA diagnosis , *BLOOD , *BACTEREMIA , *INTENSIVE care units , *CELL culture , *SCIENTIFIC observation , *CHILDREN'S hospitals , *PEDIATRICS , *RETROSPECTIVE studies , *ENTEROBACTERIACEAE , *ESCHERICHIA coli diseases , *PATHOGENIC microorganisms , *AEROBIC bacteria , *ANAEROBIC bacteria , *BLOODBORNE infections - Abstract
Background Several reports have suggested that routine use of anaerobic blood culture bottles together with aerobic bottles may improve blood culture positivity. However, the information is still limited regarding the utility of anaerobic blood culture bottles in the pediatric intensive care unit (PICU), where bacteremia due to anaerobic bacteria is relatively rare. Methods A retrospective observational study was conducted at a PICU in a tertiary children's hospital in Japan from May 2016 to January 2020. Patients aged ≤15 years old with bacteremia, for which both aerobic and anaerobic blood cultures were submitted, were included in the study. We investigated whether the positive blood culture cases were from aerobic or anaerobic bottles. We also compared the amount of blood inoculated into culture bottles to determine the effect of blood volume on the rate of detection. Results During the study period, a total of 276 positive blood cultures from 67 patients were included in this study. Among the paired blood culture bottles, 22.1% were positive only for the anaerobic bottles. Escherichia coli and Enterobacter cloacae were the most common pathogens that were detected in anaerobic bottles only. Obligate anaerobic bacteria were detected in 2 (0.7%) bottles. There was no significant difference in the amount of blood inoculated into aerobic and anaerobic culture bottles. Conclusions The use of anaerobic blood culture bottles in the PICU may increase the detection rate of facultative anaerobic bacteria. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
233. Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease.
- Author
-
Shoji, Kensuke, Funaki, Takanori, Yamada, Masaki, Mikami, Masashi, Miyake, Kozue, Ueno, Saki, Tao, Chiaki, Myojin, Shota, Aiba, Hiroyuki, Matsui, Toshihiro, Ogimi, Chikara, Kato, Hitoshi, and Miyairi, Isao
- Subjects
- *
SARS-CoV-2 , *YOUNG adults , *ANTIBODY formation , *MECKEL diverticulum , *COVID-19 vaccines , *MESSENGER RNA - Abstract
Data are limited regarding the safety of and antibody response to the BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid vaccine in adolescents and young adults with underlying disease. This prospective observational study enrolled patients age 12–25 years with chronic underlying disease who received 2 doses of BNT162b2. A 18-item questionnaire was used to assess adverse events within 7 days post-vaccination, and data regarding severe adverse events were collected from electronic medical records. An antibody titer for the receptor-binding domain of the spike protein in SARS-CoV-2 was used to assess antibody response after the second vaccine dose. Study participants were 429 patients (241 [56.2%] age 12–15 years; 188 [43.8%] age 16–25 years). The most common underlying diseases were genetic or chromosomal abnormalities and/or congenital anomalies, followed by endocrine or metabolic diseases; 32% of participants were immunocompromised. Severe adverse events were observed after the second dose in 1 (0.4%) patient age 12–15 years and in 2 (1.1%) patients age 16–25 years; all patients recovered. Seropositivity after the second vaccine dose was 99.0%. The geometric mean antibody titer was higher in patients age 12–15 years versus 16–25 years (1603.3 [1321.8–1944.7] U/mL vs. 949.4 [744.2–1211.0] U/mL). Compared with immunocompetent patients, immunocompromised patients had a lower antibody titer (2106.8 [1917.5–2314.7] U/mL vs. 467.9 [324.4–674.8] U/mL). Vaccination with BNT162b2 was acceptably safe and immunogenic for adolescents and young adults with underlying disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
234. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods.
- Author
-
Shoji, Kensuke, Tsuzuki, Shinya, Akiyama, Takayuki, Matsunaga, Nobuaki, Asai, Yusuke, Suzuki, Setsuko, Iwamoto, Noriko, Funaki, Takanori, Yamada, Masaki, Ozawa, Nobuaki, Yamaguchi, Koushi, Miyairi, Isao, and Ohmagari, Norio
- Subjects
- *
SARS-CoV-2 , *SARS-CoV-2 Omicron variant , *SARS-CoV-2 Delta variant , *SMELL disorders , *COVID-19 , *PREGNANT women - Abstract
Information regarding effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant strains on clinical manifestations and outcomes of coronavirus disease 2019 (COVID-19) in pregnant women is limited. A retrospective observational study was conducted using the data from the nationwide COVID-19 registry in Japan. We identified pregnant patients with symptomatic COVID-19 hospitalized during the study period. The Delta and Omicron variants of concern (VOC) predominant periods were defined as August 1 to December 31, 2021 and January 1 to May 31, 2022, respectively. Clinical characteristics were compared between the patients in the Delta and Omicron VOC periods. In addition, logistic regression analysis was performed to identify risk factors for developing moderate-to-severe COVID-19. During the study period, 310 symptomatic COVID-19 cases of pregnant women were identified; 111 and 199 patients were hospitalized during the Delta and Omicron VOC periods, respectively. Runny nose and sore throat were more common, and fatigue, dysgeusia, and olfactory dysfunction were less common manifestations observed in the Omicron VOC period. In the multivariable logistic regression analysis, onset during the later stage of pregnancy (OR: 2.08 [1.24–3.71]) and onset during the Delta VOC period (OR: 2.25 [1.08–4.90]) were independently associated with moderate-to-severe COVID-19, whereas two doses of SARS-CoV-2 vaccine were protective against developing moderate-to-severe COVID-19 (OR: 0.34 [0.13–0.84]). Clinical manifestations of COVID-19 in pregnant women differed between the Delta and Omicron VOC periods. SARS-CoV-2 vaccination was still effective in preventing severe COVID-19 throughout the Delta and Omicron VOC periods. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
235. Chlamydia psittaci Genetic Variants Differ in Virulence by Modulation of Host Immunity.
- Author
-
Miyairi, Isao, Laxton, Jonathan D., Wang, Xiaofei, Obert, Caroline A., Tatireddigari, Venkat R. R. Arva, Rooijen, Nico van, Hatch, Thomas P., and Byrne, Gerald I.
- Subjects
- *
CHLAMYDIA , *MICROBIAL virulence , *IMMUNITY - Abstract
An abstract of the article "Chlamydia psittaci Genetic Variants Differ in Virulence by Modulation of Host Immunity," by Isao Miyairi and colleagues is presented.
- Published
- 2011
- Full Text
- View/download PDF
236. The consequence of financial incentives for not prescribing antibiotics: a Japan's nationwide quasi-experiment.
- Author
-
Okubo, Yusuke, Nishi, Akihiro, Michels, Karin B, Nariai, Hiroki, Kim-Farley, Robert J, Arah, Onyebuchi A, Uda, Kazuhiro, Kinoshita, Noriko, and Miyairi, Isao
- Subjects
- *
ANTIBIOTICS , *COMMUNICABLE diseases , *MOTIVATION (Psychology) , *RESPIRATORY infections , *RESEARCH funding - Abstract
Background: For addressing antibiotic overuse, Japan designed a health care policy in which eligible medical facilities could claim a financial reward when antibiotics were not prescribed for early-stage respiratory and gastrointestinal infections. The policy was introduced in a pilot manner in paediatric clinics in April 2018.Methods: We conducted a quasi-experimental, propensity score-matched, difference-in-differences (DID) design to determine whether the nationwide financial incentives for appropriate non-prescribing of antibiotics as antimicrobial stewardship [800 JPY (≈7.3 US D) per case] were associated with changes in prescription patterns, including antibiotics, and health care use in routine paediatric health care settings at a national level. Data consisted of 9 253 261 cases of infectious diseases in 553 138 patients treated at 10 180 eligible or ineligible facilities.Results: A total of 2959 eligible facilities claimed 316 770 cases for financial incentives and earned 253 million JPY (≈2.29 million USD). Compared with ineligible facilities, the introduction of financial incentives in the eligible facilities was associated with an excess reduction in antibiotic prescriptions [DID estimate, -228.6 days of therapy (DOTs) per 1000 cases (95% CI, -272.4 to -184.9), which corresponded to a relative reduction of 17.8% (95% CI, 14.8 to 20.7)]. The introduction was also associated with excess reductions in drugs for respiratory symptoms [DID estimates, -256.9 DOTs per 1000 cases (95% CI, -379.3 to -134.5)] and antihistamines [DID estimate, -198.5 DOTs per 1000 cases (95% CI, -282.1 to -114.9)]. There was no excess in out-of-hour visits [DID estimate, -4.43 events per 1000 cases (95% CI, -12.8 to 3.97)] or hospitalizations [DID estimate, -0.08 events per 1000 cases (95% CI, -0.48 to 0.31)].Conclusions: Our findings suggest that financial incentives to medical facilities for not prescribing antibiotics were associated with reductions in prescriptions for antibiotics without adverse health care consequences. Japan's new health policy provided us with policy options for immediately reducing inappropriate antibiotic prescriptions by relatively small financial incentives. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
237. Vancomycin Hypersensitivity Diagnosed by Lymphocyte Blast Transformation
- Author
-
P. Tran, Nguyen, Katcher, Jeremy, Rohman, Erin, Francis Hall, Mary, F. Michael, Christie, Miyairi, Isao, and Betty Lew, D.
- Abstract
A 15-year-old male admitted for Pott's puffy tumor developed recurrent episodes of fever, diffuse morbilliform rash, eosinophilia, and tubulointerstitial nephritis while on multiple antibiotics. Lymphocyte blast transformation (LBT), a method of detecting cellular immune response by measuring levels of interferon-? (IFN-?), was used to diagnose vancomycin hypersensitivity and guide antibiotic selection.
- Published
- 2011
- Full Text
- View/download PDF
238. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19) in Pregnant Women: A Propensity Score–Matched Analysis of Data From the COVID-19 Registry Japan.
- Author
-
Shoji, Kensuke, Tsuzuki, Shinya, Akiyama, Takayuki, Matsunaga, Nobuaki, Asai, Yusuke, Suzuki, Setsuko, Iwamoto, Noriko, Funaki, Takanori, Yamada, Masaki, Ozawa, Nobuaki, Yamaguchi, Koushi, Miyairi, Isao, and Ohmagari, Norio
- Subjects
- *
EVALUATION of medical care , *COVID-19 , *MULTIVARIATE analysis , *PREGNANT women , *RETROSPECTIVE studies , *RISK assessment , *SEVERITY of illness index , *PREGNANCY - Abstract
Background Several studies have investigated whether pregnancy is a risk factor for developing severe coronavirus disease 2019 (COVID-19); however, the results remain controversial. In addition, the information regarding risk factors for developing severe COVID-19 in pregnant women is limited. Methods A retrospective cohort study analyzing the data from the nationwide COVID-19 registry in Japan was conducted. Propensity score–matched analysis was performed to compare COVID-19 severity between pregnant and nonpregnant women. Multivariate analysis was also conducted to evaluate risk factors for developing moderate-to-severe COVID-19 in pregnant women. Results During the study period, 254 pregnant and 3752 nonpregnant women of reproductive age were identified. After propensity score matching, 187 pregnant women and 935 nonpregnant women were selected. A composite outcome of moderate-to-severe COVID-19 was more frequently observed in pregnant women than that of nonpregnant women (n = 18 [9.6%] vs n = 46 [4.9%]; P = .0155). In multivariate analysis, the presence of underlying diseases and being in the second-to-third trimester of pregnancy were recognized as risk factors for moderate-to-severe COVID-19 in pregnant women (odds ratio [95% confidence interval]: 5.295 [1.21–23.069] and 3.871 [1.201–12.477], respectively). Conclusions Pregnancy could be a risk factor for moderate-to-severe COVID-19 for women in Japan. In addition to the presence of comorbidities, advanced pregnancy stages may contribute to greater risks for developing moderate-to-severe COVID-19 in pregnant women. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
239. Clinical evaluation of a new rapid immunochromatographic test for detection of Bordetella pertussis antigen.
- Author
-
Okada, Kenji, Horikoshi, Yuho, Nishimura, Naoko, Ishii, Shigeki, Nogami, Hiroko, Motomura, Chikako, Miyairi, Isao, Tsumura, Naoki, Mori, Toshihiko, Ito, Kenta, Honma, Shinichi, Nagai, Kensuke, Tanaka, Hiroshi, Hayakawa, Toru, Abe, Chiharu, and Ouchi, Kazunobu
- Subjects
- *
WHOOPING cough , *BORDETELLA pertussis , *ANTIGENS , *POLYMERASE chain reaction - Abstract
A more rapid and less complicated test to diagnose pertussis is required in clinical settings. We need to detect Bordetella pertussis, which mainly causes pertussis, as early as possible, because pertussis is more likely to become severe in infants, and people around them can easily become a source of infection due to its strong infectivity. Nevertheless, methods that can detect B. pertussis rapidly and efficiently are lacking. Therefore, we developed a new immunochromatographic antigen kit (ICkit) for the early diagnosis of pertussis. The ICkit detects B. pertussis antigens in a nasopharyngeal swab without equipment and provides the result in about 15 min with a simple procedure. Additionally, a prospective study to evaluate the ICkit was conducted in 11 medical institutions, involving 195 cases with suspected pertussis. Compared with the real-time polymerase chain reaction (rPCR), the sensitivity and specificity of the ICkit were 86.4% (19/22) and 97.1% (168/173), respectively. The ICkit detected the antigen in both children and adults. Furthermore, the ICkit detected the antigen until the 25th day from the onset of cough, when rPCR detected the antigen. Thus, the ICkit demonstrated a high correlation with rPCR and would help diagnose pertussis more rapidly and efficiently. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
240. Epidemiology of group B streptococcal disease in infants younger than 1 year in Japan: a nationwide surveillance study 2016–2020.
- Author
-
Shibata, Meiwa, Matsubara, Kousaku, Matsunami, Kunihiro, Miyairi, Isao, Kasai, Masashi, Kai, Masahiko, Katayama, Yoshinori, Maruyama, Tomoko, and Le Doare, Kirsty
- Subjects
- *
STREPTOCOCCAL diseases , *INFANT diseases , *STREPTOCOCCUS agalactiae , *EPIDEMIOLOGY , *DEATH rate , *TOXIC shock syndrome , *MATERNAL mortality - Abstract
We aimed to define the burden and clinical features of invasive group B streptococcus (GBS) disease in infants younger than 1 year in Japan, to explore transmission route of late-onset disease (LOD), and to identify risk factors associated with recurrent GBS disease. We conducted a retrospective, questionnaire-based nationwide surveillance study between 2016 and 2020. A total of 875 GBS cases were identified, including 186 early-onset disease, 628 LOD, and 61 ultra-late-onset disease. Case fatality rate in each age category was 6.5%, 3.0%, and 3.3%, respectively. Patients with meningitis had neurodevelopmental sequelae in 21.5% (64/297). Annual incidence in infants younger than 1 year and in LOD significantly increased from 0.28 to 0.45/1000 livebirths (p = 0.021) and from 0.19 to 0.29/1000 livebirths (p = 0.046), respectively. Maternal colonization status at the LOD diagnosis was available for 148 mothers, of whom 21/58 (36.2%) had positive rectovaginal swabs and 42/117 (36.2%) had GBS in breastmilk culture. These two sites are potentially infectious routes in LOD. The four leading disease-causing serotypes III, Ia, Ib, and V represented 95% of the available serotypes. Thirty-one recurrent cases were identified, accounting for 3.7% of total patients. A multivariate regression analysis showed that prematurity (p = 0.029) and antepartum maternal GBS colonization (p = 0.032) were significantly associated with risk for the recurrence. Our findings indicated that GBS disease burden still remains with considerable mortality and morbidity in Japan, and provided important information for developing better strategies for the prevention of GBS disease, including maternal vaccination. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
241. Multisystem inflammatory syndrome in children after BNT162b2 messenger RNA SARS‐CoV‐2 vaccination.
- Author
-
Sakaida, Kana, Iwashima, Satoru, Katsuki, Junichiro, Sato, Keisuke, and Miyairi, Isao
- Subjects
- *
ECHOCARDIOGRAPHY , *MULTISYSTEM inflammatory syndrome , *FEVER , *COVID-19 vaccines , *ACETAMINOPHEN , *MAGNETIC resonance imaging , *DIAGNOSTIC imaging , *MESSENGER RNA , *CHEST pain , *MEDICAL referrals , *ELECTROCARDIOGRAPHY , *HOSPITAL care , *ABDOMINAL pain , *SYMPTOMS , *ADOLESCENCE - Abstract
The article presents a case study of a 15 year old male who developed multisystem inflammatory syndrome in children (MIS-C) following vaccination with the BNT162b2 mRNA SARS-CoV-2 vaccine. It is reported that the patient exhibited symptoms such as fever, chest pain, abdominal pain, and conjunctival hyperemia 50 days after the second vaccine dose. It is further reported that the patient's symptoms improved with supportive care, and imaging revealed myocardial abnormalities.
- Published
- 2023
- Full Text
- View/download PDF
242. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study.
- Author
-
Myojin, Shota, Pak, Kyongsun, Sako, Mayumi, Kobayashi, Tohru, Takahashi, Takuri, Sunagawa, Tomimasa, Tsuboi, Norihiko, Ishikura, Kenji, Kubota, Masaya, Kubota, Mitsuru, Igarashi, Takashi, Morioka, Ichiro, and Miyairi, Isao
- Subjects
- *
HEMOLYTIC-uremic syndrome , *POPULATION-based case control , *ESCHERICHIA coli , *COMMUNICABLE diseases , *GASTROENTERITIS , *CHILD development - Abstract
Background: The role of antibiotics in the treatment of Shiga toxin-producing Escherichia coli (STEC) infection is controversial. Objectives: To evaluate the association between treatment (antibiotics, antidiarrheal agents, and probiotics) for STEC infection and hemolytic uremic syndrome (HUS) development. Patients and methods: We performed a population-based matched case-control study using the data from the National Epidemiological Surveillance of Infectious Diseases (NESID) between January 1, 2017 and December 31, 2018. We identified all patients with STEC infection and HUS as cases and matched patients with STEC infection without HUS as controls, with a case-control a ratio of 1:5. Further medical information was obtained by a standardized questionnaire. Multivariable conditional logistic regression model was used. Results: 7760 patients with STEC infection were registered in the NESID. 182 patients with HUS and 910 matched controls without HUS were selected. 90 patients with HUS (68 children and 22 adults) and 371 patients without HUS (266 children and 105 adults) were included in the main analysis. The matched ORs of any antibiotics and fosfomycin for HUS in children were 0.56 (95% CI 0.32–0.98), 0.58 (0.34–1.01). The matched ORs for HUS were 2.07 (1.07–4.03), 0.86 (0.46−1.61) in all ages treated with antidiarrheal agent and probiotics. Conclusions: Antibiotics, especially fosfomycin, may prevent the development of HUS in children, while use of antidiarrheal agents should be avoided. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
243. Change in clinical practice variations for antibiotic prescriptions across different pediatric clinics: A Japan's nationwide observational study.
- Author
-
Okubo, Yusuke, Nariai, Hiroki, Michels, Karin B., Kim-Farley, Robert J., Nishi, Akihiro, Arah, Onyebuchi A., Kinoshita, Noriko, Uda, Kazuhiro, and Miyairi, Isao
- Subjects
- *
PEDIATRIC clinics , *PHYSICIAN practice patterns , *ANTIBIOTICS , *MEDICAL prescriptions , *DRUG resistance in microorganisms - Abstract
In 2016, the Japanese government set the National Action Plan on antimicrobial resistance to reduce antibiotic prescriptions. However, the trends and variations of antibiotic prescription patterns in a routine healthcare setting during the fiscal year 2013–2018 across different clinics at a national level are unclear. This retrospective cohort study included all clinics with >100 pediatric outpatients with infectious diseases per month during the fiscal year 2013–2018 using a national database in Japan. We investigated the trends in antibiotic prescription rates and their patterns and variations across different clinics over the six years following the 2019 World Health Organization Access, Watch, Reserve antibiotic groups, and Amoxicillin Index. A total of 2278 clinics with 94,414,170 infectious disease-related visits were eligible for the study. Most clinics showed higher Watch percentages (median 85.4%; IQR, 68.5–95.1) than Access percentages (median, 13.8%; IQR, 4.2–30.7) and Amoxicillin Index (median, 13.3%; IQR, 3.9–30.4). The introduction of the Action Plan changed annual absolute reductions in the antibiotic prescription rates from −16.0 DOTs/1000 visitors (95%CI, −16.4–15.6) to −239.3 per 1000 visitors (95%CI, −240.0–238.6). However, these impacts were heterogeneous across clinics. From 2013 to 2018, 41.4% reduced the antibiotic prescription rates by >33.3% (median, −1035.5 DOTs/1000 visitors; IQR, −1519.4–680.2), 18.7% did not change the rates (median, −40.3 DOTs/1000 visitors; IQR, −168.4–68.6), and 7.3% increased the rates by >10% (499.5 DOTs per 1000 visitors; IQR, 232.6–837.5). We observed the National Action Plan's impacts and extensive prescription variations across different pediatric clinics. However, one-fourth of clinics did not improve antibiotic prescription patterns even after introducing the Action Plan. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
244. Drastic reduction in pneumococcal meningitis in children owing to the introduction of pneumococcal conjugate vaccines: Longitudinal analysis from 2002 to 2016 in Japan.
- Author
-
Iwata, Satoshi, Takata, Misako, Morozumi, Miyuki, Miyairi, Isao, Matsubara, Keita, and Ubukata, Kimiko
- Subjects
- *
PNEUMOCOCCAL meningitis , *PNEUMOCOCCAL vaccines , *LEUKOCYTE count , *STREPTOCOCCUS pneumoniae , *PROGNOSIS , *CEREBROSPINAL fluid - Abstract
The characteristics of pneumococcal isolates and their associations with outcomes in pediatric meningitis are unclear. This study aimed to clarify serotypes and resistance genotypes of Streptococcus pneumoniae from children with meningitis and evaluate the patient prognoses and backgrounds. Large-scale surveillance was conducted from 2002 to 2016 through periods I–V. Serotypes and penicillin (PEN) resistance genotypes were analyzed for pneumococcal isolates (n = 459) and cerebrospinal fluid (CSF) samples (n = 25). Furthermore, underlying diseases (n = 251), prognoses (n = 202), and laboratory data were evaluated. The number of meningitis cases decreased drastically after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7) to −53.6% and after switching to PCV13 to −70.2%. In particular, this reduction was apparent at ≤3 years of age. The proportion of the PCV7 serotype decreased sharply from 70.1% before introduction to 2.6% during period V; however, the non-vaccine type increased from 17.5% to 87.2%. The PEN resistance rate (gPRSP) was decreased from approximately 49% to 12.2% during period V. Among cases revealed prognosis, sequelae and mortality rates were 16.3% and 5.4%, respectively. The rate of the patients with underlying diseases was 26.3% and relatively high in ≥6 years. Laboratory data associated with a poor prognosis were low white blood cell count (<12.7 × 103/μL), low platelet count (<28.1 × 104/μL), low CSF-glucose (<36 mg/dL), and high CSF-protein (≥142 mg/dL). Changes in serotype prevalence warrant continuous monitoring to observe future trends of pneumococcal meningitis, and further developments in multivalent conjugate vaccines are required. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
245. The JAID/JSC guidelines to Clinical Management of Infectious Disease 2017 concerning male urethritis and related disorders.
- Author
-
Hamasuna, Ryoichi, Yasuda, Mitsuru, Takahashi, Satoshi, Uehara, Shinya, Kawai, Yasuhiro, Miyairi, Isao, Arakawa, Soichi, and Kiyota, Hiroshi
- Subjects
- *
TRICHOMONIASIS , *URETHRITIS , *GONORRHEA , *COMMUNICABLE diseases - Abstract
6 Non-chlamydial non-gonococcal urethritis [Executive summary] • Male urethritis in which neither N. gonorrhoeae nor C. trachomatis is detected is called non-chlamydial non-gonococcal urethritis (I, B). Non-gonococcal urethritis in which chlamydia is detected is called chlamydial urethritis, and urethritis in which neither gonococcus nor chlamydia is detected is called non-chlamydial non-gonococcal urethritis (I, B). Urethritis and cervicitis are frequently caused by Neisseria gonorrhoeae and Chlamydia trachomatis, and gonococcal urethritis and cervicitis and chlamydial urethritis and cervicitis have been used as terms to indicate these conditions. 4 Non-gonococcal urethritis • Urethritis in which gonococci are not detected is called non-gonococcal urethritis (I, A). Urethritis is classified into gonococcal and non-gonococcal urethritis depending on detection or no detection of gonococcus. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
246. Determinants of clinic doctors' attitudes concerning antimicrobial prescription for patients with common colds or bronchitis: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases
- Author
-
Morioka, Shinichiro, Gu, Yoshiaki, Tsuzuki, Shinya, Fujitomo, Yumiko, Soeda, Hiroshi, Nakahama, Chikara, Hasegawa, Naoki, Maesaki, Shigefumi, Maeda, Masayuki, Matsumoto, Tetsuya, Miyairi, Isao, and Ohmagari, Norio
- Subjects
- *
COMMON cold , *COMMUNICABLE diseases , *PHYSICIANS , *BRONCHITIS , *INAPPROPRIATE prescribing (Medicine) , *PEDIATRICIANS - Abstract
In 2019, the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases reported nationwide, cross-sectional questionnaire survey data investigating the clinical status of clinic doctors' attitudes to antimicrobial stewardship. This study aimed to identify factors determining clinic doctors' attitudes concerning antimicrobial prescription for patients with a common cold or bronchitis. In February 2018, 1500 randomly selected community-based medical clinics in Japan were sent a questionnaire. Primary and secondary endpoints were clinic doctors' attitudes concerning antimicrobial prescription, and antimicrobial medication types prescribed for patients with a common cold or bronchitis, respectively. We used multivariable linear regression analysis to identify factors associated with primary and secondary outcomes. We analyzed 269 of 274 responses (response rate, 18.3%). Linear regression analysis was used to identify determinants of proactive attitudes to antimicrobial prescription, including whether clinic doctors encountering patients with upper respiratory symptoms and no underlying illnesses, and diagnosed with a common cold would prescribe antimicrobial medication (β = 0.283, t = 4.279, p = 0.000); whether clinic doctors frequently experienced requests from patients (or their families) with a common cold to prescribe antimicrobial medication (β = 0.389, t = 6.133, p = 0.000), and; clinic doctors' awareness of antimicrobial stewardship in the past year (β = −0.157, t = −2.456, p = 0.015). Determinants of proactive attitudes to prescribing broader-spectrum antimicrobials for patients with a common cold included clinic doctors' attitudes concerning antimicrobial prescription (β = 0.165, t = 2.622, p = 0.009), whether the respondent was a pediatrician (β = −0.288, t = −4.583, p = 0.000), and clinic doctors' attitudes to antimicrobial prescription (β = 0.262, t = 4.075, p = 0.000) for patients with bronchitis. This study identified factors among clinic doctors that determined their attitudes to antimicrobial prescription concerning patients with a common cold or bronchitis. Identification and targeting of clinic doctors who unnecessarily prescribe antimicrobial medication is urgently required to promote antimicrobial stewardship in an outpatient setting. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
247. Molecular epidemiological characterization in mucoid-type Streptococcus pneumoniae isolates obtained from invasive pneumococcal disease patients in Japan.
- Author
-
Ubukata, Kimiko, Wajima, Takeaki, Takata, Misako, Murayama, Somay Y., Morozumi, Miyuki, Mukae, Hiroshi, Ishida, Tadashi, Miyairi, Isao, Kiyota, Hiroshi, and Iwata, Satoshi
- Subjects
- *
STREPTOCOCCUS pneumoniae , *KLEBSIELLA pneumoniae , *KLEBSIELLA , *PNEUMOCOCCAL vaccines , *PHENOTYPES , *ANTI-infective agents , *GENE clusters , *KLEBSIELLA infections - Abstract
Streptococcus pneumoniae with a mucoid-type capsule is associated with invasive pneumococcal diseases (IPDs). Despite the introduction of pneumococcal vaccines, IPDs caused by mucoid-type isolates are still prevalent. The present study aimed to characterize mucoid-type S. pneumoniae isolated from IPD patients throughout Japan in 2017 (post-vaccination era). A total of 225 mucoid-type isolates were collected. The serotype, antimicrobial susceptibility, and multilocus sequence type of these isolates were determined. The prevalence of IPDs caused by mucoid-type isolates was high in adults, especially in the elderly (≥65 years of age), and prognosis in these patients was significantly poor. Of the mucoid-type isolates, the predominant serotype was serotype 3 (84.4%), and the remaining were serotypes 37 (15.1%) and 8 (0.4%). Antimicrobial susceptibility showed that most mucoid isolates exhibited the penicillin-intermediate resistant S. pneumoniae genotype (gPISP). However, the serotype 3 isolate exhibited the penicillin-resistant S. pneumoniae genotype (gPRSP). This gPRSP isolate was classified into ST166, which is related to serotypes 9 V and 11 strains. Sequence analysis of the capsule-coding regions and its flanking regions indicated that recombination occurred upstream and downstream of the capsule-coding region, suggesting that gPRSP (serotype 9 V/ST166) obtaining the type-3 capsule gene cluster resulted in the emergence of gPRSP (serotype 3/ST166). Our findings indicated that IPDs caused by mucoid-type S. pneumoniae are still a serious concern and mucoid-type S. pneumoniae with novel phenotype could emerge via capsular switching in response to environmental changes such as introduction of vaccines and improper use of antimicrobial agents. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
248. Clinical characteristics of bacteremic urinary tract infection due to third-generation cephalosporin-resistant Escherichia coli in children.
- Author
-
Hashimoto, Risa, Shoji, Kensuke, Ishiguro, Akira, and Miyairi, Isao
- Subjects
- *
URINARY tract infections , *ESCHERICHIA coli , *CHILD patients - Abstract
Clinical characteristics of bacteremic urinary tract infection due to third-generation cephalosporin-resistant Escherichia coli in children remain unclear. We conducted a case control study comparing the clinical information of the third-generation cephalosporin-susceptible group (S- E. coli group) and the third-generation cephalosporin-resistant group (R- E. coli group). The R-E. coli group included extended-spectrum beta-lactamases (ESBLs) or AmpC-producing E. coli. We identified 52 cases of bacteremic UTI due to E. coli ; 42 cases were in the S-E. coli group and 10 cases were in the R-E. coli group. Empiric antibiotics were more likely to be inappropriate for pediatric patients with bacteremic urinary tract infection due to third-generation cephalosporin-resistant E. coli than those infected by susceptible E. coli (60% vs. 0%, P < 0.001). However, duration of fever and rate of relapse were not significantly different. The outcomes of bacteremic UTI due to multidrug-resistant E. coli in children were satisfactory regardless of susceptibility to empiric antibiotics. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
249. National trends in appropriate antibiotics use among pediatric inpatients with uncomplicated lower respiratory tract infections in Japan.
- Author
-
Okubo, Yusuke, Uda, Kazuhiro, Kinoshita, Noriko, Horikoshi, Yuho, Miyairi, Isao, Michihata, Nobuaki, Matsui, Hiroki, Fushimi, Kiyohide, and Yasunaga, Hideo
- Subjects
- *
RESPIRATORY infections , *ANTIBIOTICS , *CLUSTER analysis (Statistics) , *BETA-lactamase inhibitors , *HIGH-income countries - Abstract
Japan was ranked as the worst country of 36 high-income countries in terms of oral antibiotic consumptions for children. Knowing the patterns and variations of antibiotic use for pediatric inpatients with uncomplicated respiratory infections is an important step to promote judicious antibiotic use. Discharge records were extracted for children aged between 3 months and 15 years with acute lower respiratory tract infections for the fiscal years 2010–2014 using a national inpatient database in Japan. We investigated the trends in antibiotic use using mixed effect regression models and ascertained variations and clustering of the practice patterns across different hospitals using unsupervised machine learning methodology. A total of 280,298 children were included in the study. Total and broad-spectrum antibiotic use, except for fluoroquinolone, showed decreasing trends from 2010 to 2014. Additionally, the proportions of patients who received no antibiotics or only penicillin increased from 17.1% to 9.9% in 2010 to 24.5% and 13.7% in 2014, respectively. Cluster analysis showed that only one-quarter of hospitals used no antibiotics for 28.8% of children and only penicillin for 53.7% of children. In the remaining clusters of hospitals, the piperacillin, 3rd generation cephalosporins, and penicillin beta-lactamase inhibitors were used for 68.5%, 68.5%, and 69.6% of the patients who received antibiotics. Slightly increasing trends in narrow-spectrum antibiotics were observed. However, the treatment strategy in only one-quarter of hospitals was consistent with the current recommendations. Hospital level interventions to promote and monitor antibiotic use could be helpful to improve antibiotic use for pediatric inpatients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
250. The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan.
- Author
-
Kinoshita, Noriko, Komura, Makoto, Tsuzuki, Shinya, Shoji, Kensuke, and Miyairi, Isao
- Subjects
- *
CHILDREN'S hospitals , *RESPIRATORY infections , *URINARY tract infections , *MEDICAL prescriptions , *TIME series analysis - Abstract
Antimicrobial stewardship programs (ASP) for oral antibiotics is still uncommon, despite the fact that oral antibiotics prescription accounts for 90% of total antibiotic consumption in developed countries. We introduced preauthorization and prospective audit and feedback (PAF) system on broad-spectrum oral antimicrobials as a part of ASP intervention from October 2015 in a tertiary children's hospital in Japan. Antimicrobial consumption and cost of targeted oral antimicrobials decreased from 11.1 days of therapy (DOT) per 1000 outpatient visits and 860,040 yen ($ 7167: 1 $ = 120 yen) to 1.9 DOT per 1000 outpatient visits and 142,200 yen ($ 1185) annually, respectively (p < 0.001). Interrupted time-series analysis showed that prescriptions for targeted antimicrobials decreased rapidly after initiation of preauthorization (p < 0.001). Prescriptions for non-targeted oral antimicrobial increased temporarily (p < 0.001), but a decreasing trend was found after the initiation (p < 0.001). In pre-intervention period, the main indications for using targeted antimicrobials were upper and lower respiratory infection, urinary tract infections, prophylaxis for medical procedures and otitis media, but only 21.4% of them were appropriate prescription. The appropriate prescription rate of post -intervention period increased to 58.5%. During the study period, the susceptibility pattern of major bacteria to these antimicrobials did not change. In conclusion, introduction of the preauthorization and PAF for selected oral antimicrobials decreased the antimicrobial use of both targeted and non-targeted antimicrobials. This intervention may be an effective method of ASP for other children's hospitals. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.